Details for Patent: 11,602,603
✉ Email this page to a colleague
Which drugs does patent 11,602,603 protect, and when does it expire?
Patent 11,602,603 protects XHANCE and is included in one NDA.
This patent has thirty-one patent family members in fifteen countries.
Drugs Protected by US Patent 11,602,603
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,602,603
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008306635 | ⤷ Sign Up | |||
| Brazil | PI0817502 | ⤷ Sign Up | |||
| Canada | 2701409 | ⤷ Sign Up | |||
| China | 101918061 | ⤷ Sign Up | |||
| Denmark | 2653183 | ⤷ Sign Up | |||
| European Patent Office | 2197525 | ⤷ Sign Up | |||
| European Patent Office | 2653183 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
